Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0,47%
1 067,36
+4,96
+0,47%
—1 062,401 064,141 071,991 061,02——
SIXC
Communications
SIXC
Communications
SIXC
-0,54%
603,48
-3,26
-0,54%
—606,74606,74609,84602,33——
SIXE
Energy
SIXE
Energy
SIXE
+0,54%
1 244,93
+6,72
+0,54%
—1 238,211 236,601 247,741 232,10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0,68%
1 730,38
+11,77
+0,68%
—1 718,611 723,231 741,481 717,47——
SIXM
Financials
SIXM
Financials
SIXM
+0,33%
639,47
+2,10
+0,33%
—637,37638,27642,30638,27——
SIXR
Staples
SIXR
Staples
SIXR
+0,16%
854,95
+1,36
+0,16%
—853,59854,05858,19851,34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,11%
218,56
+0,23
+0,11%
—218,33218,33219,73217,15——
SIXT
Technology
SIXT
Technology
SIXT
+1,02%
3 631,59
+36,78
+1,02%
—3 594,813 620,103 657,473 615,34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,80%
915,77
+7,23
+0,80%
—908,54909,50917,35907,07——
SIXV
Health care
SIXV
Health care
SIXV
+1,19%
1 512,81
+17,81
+1,19%
—1 495,001 499,611 517,101 499,61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,41%
2 408,21
+9,90
+0,41%
—2 398,312 406,822 421,802 404,22——
CUP:FRA
Chugai Pharmaceutical Co Ltd
43,28 €
+3,84%
(+1,60) 1D
22 მაი, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for CUP...
Open
43,02 €
High
43,28 €
Low
43,02 €
Mkt. cap
13,58 ტრლ.
Avg. vol.
19,00
Volume
0,00
52-wk high
56,26 €
52-wk low
33,02 €
No. of employees
5 ათ.
News stories
From sources across the web
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOოსამუ ოკუდა
Employees5,1 ათ.
Founded10 მარ. 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
290,00 მლრ.
333,18 მლრ.
346,30 მლრ.
321,75 მლრ.
Cost of goods sold
88,07 მლრდ.
100,24 მლრ.
87,56 მლრდ.
92,79 მლრდ.
Cost of revenue
88,07 მლრდ.
100,24 მლრ.
87,56 მლრდ.
92,79 მლრდ.
Research and development expenses
45,66 მლრდ.
48,60 მლრდ.
52,41 მლრდ.
41,89 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28,41 მლრდ.
27,89 მლრდ.
36,92 მლრდ.
28,90 მლრდ.
Operating expense
65,24 მლრდ.
76,45 მლრდ.
89,74 მლრდ.
70,19 მლრდ.
Total operating expenses
153,31 მლრ.
176,69 მლრ.
177,30 მლრ.
162,98 მლრ.
Operating income
136,69 მლრ.
156,48 მლრ.
169,01 მლრ.
158,76 მლრ.
Other non operating income
-636,00 მლნ.
-356,00 მლნ.
994,00 მლნ.
1,43 მლრდ.
EBT including unusual items
136,00 მლრ.
156,07 მლრ.
169,90 მლრ.
160,20 მლრ.
EBT excluding unusual items
136,00 მლრ.
156,07 მლრ.
169,90 მლრ.
160,20 მლრ.
Income tax expense
38,85 მლრდ.
44,86 მლრდ.
41,50 მლრდ.
44,78 მლრდ.
Effective tax rate
28,56%
28,74%
24,42%
27,95%
Other operating expenses
-8,83 მლრდ.
-38,00 მლნ.
405,00 მლნ.
-596,00 მლნ.
Net income
97,16 მლრდ.
111,21 მლრ.
128,41 მლრ.
115,42 მლრ.
Net profit margin
33,50%
33,38%
37,08%
35,87%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-54,00 მლნ.
-58,00 მლნ.
-95,00 მლნ.
-
Net interest expenses
-54,00 მლნ.
-58,00 მლნ.
-95,00 მლნ.
-
Depreciation and amortization charges
-
-
-
-
EBITDA
137,09 მლრ.
156,78 მლრ.
200,44 მლრ.
159,26 მლრ.
Gain or loss from assets sale
-
-
4,53 მლრდ.
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer